CENTURY THERAPEUTICS INC (IPSC) Stock Analyst Earnings Estimates
NASDAQ:IPSC - Nasdaq - US15673T1007 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.2M | 2.235M -57.02% | 7.389M 230.60% | 9.741M 31.83% | 4.08M -58.12% | 72.012M 1,665.00% | 117.93M 63.76% | 300.9M 155.15% | 552.84M 83.73% | 985.32M 78.23% | ||
| EBITDA YoY % growth | -91.13M -90.73% | -115.39M -26.62% | -112.137M 2.82% | -128.653M -14.73% | -143.942M -11.88% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -94.88M -92.92% | -123.83M -30.51% | -125.181M -1.09% | -144.579M -15.50% | -171.515M -18.63% | -186.079M -8.49% | -227.46M -22.24% | -186.66M 17.94% | 46.92M 125.14% | 271.32M 478.26% | 650.76M 139.85% | |
| Operating Margin | N/A | -2,381.35% | -5,600.94% | -1,956.68% | -1,760.75% | -4,560.75% | -315.86% | -158.28% | 15.59% | 49.08% | 66.05% | |
| EPS YoY % growth | N/A | -2.28 30.47% | -2.29 -0.44% | -1.66 27.64% | -1.35 18.55% | -1.95 -44.34% | -2.01 -3.14% | -1.31 35.03% | 0.09 107.03% | 1.53 1,566.67% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.43 33.49% | -0.45 0.72% | -0.44 -17.03% | -0.46 -23.12% | -0.48 -10.61% | -0.48 -7.31% | -0.49 -10.09% | -0.49 -7.48% | -0.50 -4.52% |
| Revenue Q2Q % growth | 2.333M 770.52% | 2.749M 221.52% | 2.888M 274.58% | 2.908M 267.64% | 2.848M 22.07% | 1.02M -62.90% | 1.02M -64.68% | 1.02M -64.92% | 1.02M -64.19% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -41.054M -34.09% | -39.882M -27.38% | -42.16M -21.31% | -43.418M -24.80% | -45.526M -10.89% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.37 32.73% | -0.46 | 0.09 | 19.03% |
| Q2 2024 Q2Q % growth | -0.38 32.14% | -0.47 | 0.09 | 19.26% |
| Q1 2024 Q2Q % growth | -0.45 15.09% | -0.51 | 0.06 | 12.12% |
| Q4 2023 Q2Q % growth | -0.65 -18.18% | -0.57 | -0.08 | -14.97% |
| Q3 2023 Q2Q % growth | -0.55 -3.77% | -0.52 | -0.03 | -5.20% |
| Q2 2023 Q2Q % growth | -0.56 -3.70% | -0.56 | 0.00 | -0.88% |
| Q1 2023 Q2Q % growth | -0.53 19.70% | -0.53 | 0.00 | 0.73% |
| Q4 2022 Q2Q % growth | -0.55 -129.17% | -0.60 | 0.05 | 9.01% |
| Q3 2022 Q2Q % growth | -0.53 -10.42% | -0.61 | 0.08 | 12.65% |
| Q2 2022 Q2Q % growth | -0.54 72.02% | -0.53 | -0.01 | -2.60% |
| Q1 2022 Q2Q % growth | -0.66 | -0.46 | -0.20 | -43.00% |
| Q4 2021 Q2Q % growth | -0.24 | -0.49 | 0.25 | 50.72% |
| Q3 2021 Q2Q % growth | -0.48 | -0.41 | -0.07 | -17.65% |
| Q2 2021 Q2Q % growth | -1.93 | -0.43 | -1.50 | -354.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 791K 434.46% | 2.064M | -1.273M | -61.68% |
| Q2 2024 Q2Q % growth | 771K 678.79% | 1.97M | -1.199M | -60.86% |
| Q1 2024 Q2Q % growth | 855K -50.29% | 1.287M | -432K | -33.57% |
| Q4 2023 Q2Q % growth | 268K -48.46% | 1.874M | -1.606M | -85.70% |
| Q3 2023 Q2Q % growth | 148K -93.33% | 1.185M | -1.037M | -87.51% |
| Q2 2023 Q2Q % growth | 99K -92.93% | 1.164M | -1.065M | -91.49% |
| Q1 2023 Q2Q % growth | 1.72M 62.26% | 1.336M | 384K | 28.74% |
| Q4 2022 Q2Q % growth | 520K | 2.009M | -1.489M | -74.12% |
| Q3 2022 Q2Q % growth | 2.22M | 1.151M | 1.069M | 92.88% |
| Q2 2022 Q2Q % growth | 1.4M | 975.559K | 424.441K | 43.51% |
| Q1 2022 Q2Q % growth | 1.06M | 5.1M | -4.04M | -79.22% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.92% | 0% | 3.51% |
| Revenue | 3.73% | 1.83% | 0.01% | -4.04% |